ZA-001

N/A

Report date: 2025/05/09 16:23:19
NME

Base Information

Drug NameZA-001
Drug Alias NameZA-001
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionProstatic NeoplasmsNeoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Yunke Pharmaceutical Co LtdZhong'ao Biopharmaceutical Technology (Guangdong) Co LtdSichuan University
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionProstatic NeoplasmsCondylomata Acuminata
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A